Miclo0.05%

Clobetasone butyrate is a moderately potent topical corticosteroid used for the treatment of eczema and dermatitis of various types, including:

• Atopic eczema
• Photodermatitis
• Otitis externa (outer ear inflammation)
• Primary irritant and allergic contact dermatitis, including napkin (diaper) rash
• Intertrigo (skin fold irritation)
• Prurigo nodularis
• Seborrhoeic dermatitis
• Insect bite reactions

Clobetasone butyrate may also be used as maintenance therapy between courses of a more potent topical steroid, once an acute flare has been brought under control.

Contains Miclo 0.05% 0.05% as the active ingredient in a topical cream or ointment base.

Clobetasone butyrate is a topical corticosteroid classified as moderately potent, sitting between mild preparations like hydrocortisone 1% and more potent steroids like betamethasone. It is used for short-term flare management of eczema, dermatitis, and related inflammatory skin conditions, and is notable for having relatively little effect on the body's hypothalamic-pituitary-adrenal axis compared to more potent steroids, making it a reasonably well-tolerated option even for use on more sensitive skin areas, such as the face, when used appropriately and for limited periods.

Therapeutic Class: Topical Corticosteroid (Moderate Potency)

Clobetasone butyrate is absorbed through the skin to a variable degree depending on the site of application, skin condition, and whether an occlusive dressing is used; absorption is generally low with correct use on intact skin over limited areas, which is reflected in its comparatively low effect on plasma cortisol levels even with regular short-term use, distinguishing it from more potent topical steroids.

• Apply a thin layer to the affected skin only, gently rubbing in until absorbed
• Wash hands after application, unless the hands are the area being treated
• Use in combination with regular emollients (moisturisers), applying the emollient separately (allow some time between the two, or apply emollient first and steroid second, per your pharmacist's advice)
• Do not use under an occlusive dressing or bandage unless specifically directed by a doctor, since this significantly increases absorption
• Do not use for prolonged periods or on large areas of skin, especially in children, without a doctor's advice

No clinically significant systemic drug interactions are well established for topical Miclo 0.05%, given generally low systemic absorption with correct use. Avoid combining with other topical products on the same skin area without checking with a pharmacist, since layering products can alter absorption and local tolerability.

Common side effects

• Local burning, stinging, or itching at the application site
• Skin redness

Less common effects with prolonged or excessive use

• Skin thinning (atrophy), stretch marks (striae), and visible blood vessels, particularly with prolonged use or use on thin-skinned areas (face, skin folds)
• Perioral dermatitis or acneiform eruptions
• Allergic contact dermatitis to the cream itself
• Changes in skin pigmentation

Serious effects with extensive/prolonged use (rare)

• Signs of hypothalamic-pituitary-adrenal axis suppression from systemic absorption - more likely with extensive application, prolonged use, or use under occlusion, particularly in infants and young children

Pregnancy

Topical corticosteroids are generally used during pregnancy when clinically needed, at the lowest effective potency and for the shortest duration necessary; discuss use with your doctor, particularly for larger areas or more prolonged courses.

Breastfeeding

Generally considered compatible with breastfeeding when used on limited areas as directed; avoid applying to the nipple/breast area before nursing, and discuss more extensive use with a healthcare professional.

• Short-term use is intended - use to control an acute flare, not for continuous, indefinite application; if a course beyond a few weeks or repeated frequent courses seem necessary, review with a doctor.
• Use with caution in children, particularly infants, and on large areas of skin, given increased systemic absorption risk in this population; use the lowest effective potency and shortest duration.
• Avoid use on the face for prolonged periods without specific medical guidance, given increased sensitivity to steroid-related skin changes in this area.
• Do not use on infected, broken, or acutely weeping skin without appropriate treatment of the underlying infection first.
• Avoid use under occlusive dressings unless specifically directed, given significantly increased absorption.

Topical overdose in the conventional sense is unlikely with normal use, though excessive or prolonged application, particularly over large areas or under occlusion, increases the risk of the systemic and local effects described above. If accidentally ingested, contact a doctor or pharmacist for advice, particularly for a child. Discontinue use and consult a doctor if excessive local irritation or unexpected systemic symptoms occur.

Store at room temperature, below 25-30°C, away from direct sunlight, with the cap tightly closed after use. Keep out of reach of children.

• Infants and young children: Use with particular caution, given increased skin absorption relative to body size; use the lowest effective potency and shortest duration, under medical guidance, particularly for napkin (diaper) rash or extensive eczema.
• Elderly: Skin may be thinner and more prone to steroid-related changes (atrophy, bruising); use with appropriate caution.
• Facial or skin-fold use: Requires particular caution and limited duration, given thinner skin and increased absorption in these areas.

Clobetasone butyrate is generally used for short courses to control an acute flare of eczema or dermatitis, commonly a week or two, though exact duration depends on the condition and response, as directed by the prescribing doctor or pharmacist. It may also be used as periodic, brief maintenance therapy between courses of a more potent steroid; continuous, prolonged use is generally avoided without medical review.

Drug Class: Moderately potent (Class II/III) topical glucocorticoid

Clobetasone butyrate works by binding to glucocorticoid receptors in skin cells, reducing the production of inflammatory mediators such as prostaglandins and leukotrienes. This anti-inflammatory, antipruritic (itch-relieving), and vasoconstrictive action reduces the redness, swelling, and itching associated with corticosteroid-responsive skin conditions.

Clobetasone butyrate is used in children, including for napkin (diaper) rash and atopic eczema, at the same 0.05% strength as adults but with particular attention to using the lowest effective duration and avoiding extensive application, given children's proportionally greater systemic absorption risk. Use in infants and young children should generally be guided by a doctor.